1. Home
  2. VABK vs IKT Comparison

VABK vs IKT Comparison

Compare VABK & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$40.50

Market Cap

207.9M

Sector

Finance

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.70

Market Cap

240.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
IKT
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.9M
240.1M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
VABK
IKT
Price
$40.50
$1.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$5.00
AVG Volume (30 Days)
4.3K
1.2M
Earning Date
04-23-2026
03-26-2026
Dividend Yield
3.62%
N/A
EPS Growth
12.70
57.76
EPS
3.55
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$33.33
P/E Ratio
$11.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.56
$1.33
52 Week High
$44.50
$2.37

Technical Indicators

Market Signals
Indicator
VABK
IKT
Relative Strength Index (RSI) 62.06 44.65
Support Level $38.17 $1.43
Resistance Level $41.33 $1.74
Average True Range (ATR) 0.55 0.11
MACD 0.26 -0.00
Stochastic Oscillator 100.00 45.39

Price Performance

Historical Comparison
VABK
IKT

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: